Trials / Unknown
UnknownNCT04028024
Protective Effect in Cardiac Surgery Patients
Study on the Protective Effect of Inhibiting Systemic Inflammatory Response in Patients Undergoing Cardiac Surgery.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study was to verify the protective effect of inhibiting systemic inflammatory response in patients undergoing cardiac surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ulinastatin | Ulinastatin 5000U/Kg in 20 ml NS i.v. before occlusion of aorta |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2020-12-01
- Completion
- 2021-06-01
- First posted
- 2019-07-22
- Last updated
- 2019-07-22
Source: ClinicalTrials.gov record NCT04028024. Inclusion in this directory is not an endorsement.